A
A. Munirathinam
Researcher at Indian Council of Medical Research
Publications - 16
Citations - 331
A. Munirathinam is an academic researcher from Indian Council of Medical Research. The author has contributed to research in topics: Lymphatic filariasis & Population. The author has an hindex of 9, co-authored 16 publications receiving 316 citations.
Papers
More filters
Journal ArticleDOI
Dengue vector prevalence and virus infection in a rural area in south India
TL;DR: Despite circulation of all four serotypes (DENV 1–4) detected mainly during the transmission season, the high anthropophilic index of the vectors and their abundance, no human d Dengue case was reported, suggesting silent dengue transmission.
Journal ArticleDOI
Resurgence in filarial transmission after withdrawal of mass drug administration and the relationship between antigenaemia and microfilaraemia--a longitudinal study.
I. P. Sunish,R. Rajendran,T. R. Mani,A. Munirathinam,S. C. Tewari,J. Hiriyan,A. Gajanana,K. Satyanarayana +7 more
TL;DR: It is concluded that vector control would be useful as an adjuvant to chemotherapy to prevent resurgences in microfilaraemia and antigenaemia prevalence was estimated along with MFP, using immunochromatographic test (ICT) kits.
Journal ArticleDOI
Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme.
T. R. Mani,R. Rajendran,I. P. Sunish,A. Munirathinam,Natarajan Arunachalam,K. Satyanarayana,Aditya P Dash +6 more
TL;DR: This study demonstrates that mass drug co‐administration of DEC’+ ALB in Global Programme for Elimination of Lymphatic Filariasis (GPELF) targeted at the community had a synergistic and sustainable effect against soil‐transmitted helminthiasis and provided considerable ‘beyond filariasis’ benefits.
Journal ArticleDOI
Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in South India
R. Rajendran,I. P. Sunish,T. R. Mani,A. Munirathinam,S. Md. Abdullah,Natarajan Arunachalam,K. Satyanarayana +6 more
TL;DR: The results suggest that the annual, single-dose combination (DEC + ALB) mass treatment regimen has an enhanced effect against bancroftian filariasis compared to single-drug therapy.
Journal ArticleDOI
Community‐based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India
R. Rajendran,I. P. Sunish,T. R. Mani,A. Munirathinam,Natarajan Arunachalam,K. Satyanarayana,Aditya P Dash +6 more
TL;DR: The community‐based follow‐up study showed higher and sustained benefits with regard to filarial and STH infections for the two‐drug arm over the DEC alone arm, and trends suggest that at least 10 MDAs may be necessary to achieve the goal of elimination.